Analyst Expectations for AVITA Medical's Future
Portfolio Pulse from Benzinga Insights
AVITA Medical (NASDAQ:RCEL) has received positive analyst ratings in the last quarter, with 2 bullish and 3 somewhat bullish ratings. The average 12-month price target for the company, according to 5 analysts, is $28.4, which has increased by 28.1% over the past month.
September 26, 2023 | 7:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
AVITA Medical has received positive analyst ratings, which could boost investor confidence and potentially drive the stock price up in the short term.
Analyst ratings often influence investor sentiment. In this case, the positive ratings for AVITA Medical, along with an increased price target, could lead to increased investor confidence and a potential rise in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100